Megaport Limited, a global leading Network as a Service (NaaS) provider, announces plans to expand services to Mexico via a partnership with KIO Networks,...
Vanda Pharmaceuticals Inc. (Vanda) announced it has entered into a License Agreement (the License Agreement) with MSN Pharmaceuticals Inc., MSN Laboratories Private Limited (together...
Revelian, a leader in the field of emotional intelligence and game-based assessments, announced that it has rebranded as Criteria. Criteria, a market-leading SaaS talent...
AbbVie announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib) for the treatment of moderate to severe atopic dermatitis in adults...
Jacobio's self-developed global first-in-class drug Aurora A inhibitor JAB-2485 received IND (Investigational New Drug) from the FDA (Food and Drug Administration) in US. Jacobio...
